Loading chart…
PRE-MARKET
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Agrochemicals. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care.
NATCO Pharma Limited (NATCOPHARM) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The NATCOPHARM share price is ₹807.00 (+1.38% today), with a market capitalisation of ₹158B and a price-to-earnings (P/E) ratio of 12.7. MarketRipple tracks the NATCOPHARM investment thesis, the ripple-chain impact of market events on NATCO Pharma Limited, and the Healthcare sector outlook.
Open
₹799.00
High
₹821.15
Low
₹795.05
Prev. Close
₹796.05
52W High
₹1,226.80
52W Low
₹773.60
Day range
₹795.05–₹821.15
52-week range
₹773.60–₹1,226.80
Volume
712K
P/E
12.7
ROE
15.4%
D/E
0.08
Margin
32.8%
NATCO Pharma Limited (NSE: NATCOPHARM) is currently trading at ₹807.00 (+1.38%).
NATCO Pharma Limited's market capitalization is ₹158B.
NATCO Pharma Limited's price-to-earnings (P/E) ratio is 12.7.
NATCO Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on NATCO Pharma Limited currently reads neutral, based on 9 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.